The mammalian target of rapamycin （mTOR） pathway plays an important role in neuronal growth, proliferation and differentiation. To better understand the role of mTOR pathway involved in the induction of spinal cord ...The mammalian target of rapamycin （mTOR） pathway plays an important role in neuronal growth, proliferation and differentiation. To better understand the role of mTOR pathway involved in the induction of spinal cord injury, rat models of spinal cord injury were established by modified Allen＇s stall method and interfered for 7 days by intraperitoneal administration of mTOR activator adenosine triphosphate and mTOR kinase inhibitor rapamycin. At 1-4 weeks after spinal cord injury induction, the Basso, Beattie and Bresnahan locomotor rating scale was used to evaluate rat locomotor function, and immunohistochemical staining and western blot analysis were used to detect the expression of nestin （neural stem cell marker）, neuronal nuclei （neuronal marker）, neuron specific enolase, neurofilament protein 200 （axonal marker）, glial fibrillary acidic protein （astrocyte marker）, Akt, mTOR and signal transduction and activator of transcription 3 （STAT3）. Results showed that adenosine triphosphate-mediated Akt/mTOR/STAT3 pathway increased endogenous neural stem cells, induced neurogenesis and axonal growth, inhibited excessive astrogliosis and improved the locomotor function of rats with spinal cord injury.展开更多
慢性炎症是指刺激因素持续作用或其他原因导致的难以消退的炎症反应.它与许多重大疾病的发生、发展密切相关.近年来,慢性炎症在癌症发生发展中的关键作用得到普遍认可,其促癌作用的机制已成为当前生命科学研究热点之一.哺乳动物雷帕霉...慢性炎症是指刺激因素持续作用或其他原因导致的难以消退的炎症反应.它与许多重大疾病的发生、发展密切相关.近年来,慢性炎症在癌症发生发展中的关键作用得到普遍认可,其促癌作用的机制已成为当前生命科学研究热点之一.哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)是接受细胞内外各种信号、调节细胞生长与代谢的关键分子,多数肿瘤存在mTOR通路的过度激活.最近,我们与其他实验室的研究发现mTOR通路在"炎-癌"转变中起重要作用.本综述将对慢性炎症与癌症的关系、慢性炎症的促癌作用机制做一概括介绍,重点讨论mTOR信号通路介导慢性炎症促癌效应的作用、机制及未来研究方向,为慢性炎症恶性转化分子机制研究提供新的观点.展开更多
Background： Triggering receptor expressed on myeloid cell- 1 （TREM- 1） may play a vital role in mammalian target ofrapamycin （mTOR） modulation ofCD8＋ T-cell differentiation through the transcription factors T-bo...Background： Triggering receptor expressed on myeloid cell- 1 （TREM- 1） may play a vital role in mammalian target ofrapamycin （mTOR） modulation ofCD8＋ T-cell differentiation through the transcription factors T-box expressed in T-cells and eomesodermin during the immune response to invasive pulmonary aspergillosis （IPA）. This study aimed to investigate whether the roTOR signaling pathway modulates the proliferation and differentiation of CD8＋ T-cells during the immune response to I PA and the role TREM-1 plays in this process. Methods： Cyclophosphamide （CTX） was injected intraperitoneally, and Asl？e;gillus.[mnigams spore suspension was inoculated intranasally to establish the immunosuppressed IPA mouse model. After inoculation, rapamycin （2 mg-kg ·d -1） or interleukin （IL）-12 （5 μg/kg every other day） was given for 7 days. The number of CD8＋ effector memory T-cells （Tern）, expression of interferon （IFN）-y, roTOR, and ribosomal protein $6 kinase （S6K）, and the levels of IL-6, IL- 10, galactomannan （GM）, and soluble TREM- 1 （sTREM-I） were measured. Results： Viable A. fumigatus was cultured from the lung tissue of the inoculated mice. Histological examination indicated greater inflammation, hemorrhage, and lung tissue injury in both IPA and CTX ＋ IPA mice groups. The expression of mTOR and S6K was significantly increased in the CTX ＋ IPA ＋ I L- 12 group compared with the control, I PA （P = 0.01 ; P - 0.001 ）, and CTX ＋ 1PA （P = 0.034; P = 0.032） groups, but significantly decreased in the CTX ＋ IPA ＋ RAPA group （P 〈 0.001 ）. Compared with the CTX ＋ IPA group, the proportion of Tern, expression of IFN-y, and the level ofsTREM-I were significantly higher after IL-12 treatment （P = 0.024, P = 0.032, and P = 0.017, respectively）, and the opposite results were observed when the roTOR pathway was blocked by rapamycin （P 〈 0.001）. Compared with the CTX ＋ I PA and CTX ＋ I PA ＋ RAPA groups, IL-12 treatment increased IL-6 and downregulated IL- 10 as well as G M, which strengthened the immune response to the IPA infection. Conclusions： mTOR modulates CD8＋ T-cell differentiation during the immune response to IPA. TREM-1 may play a vital role in signal transduction between mTOR and the downstream immune response.展开更多
Background Neurofibromatosis type 1 （NF1） is the most common genetic syndrome predisposing patients to various tumors due to dysregulation of the Ras signaling pathway. Recent research has shown NF1 patients also su...Background Neurofibromatosis type 1 （NF1） is the most common genetic syndrome predisposing patients to various tumors due to dysregulation of the Ras signaling pathway. Recent research has shown NF1 patients also suffer a spectrum of bone pathologies. The pathogenesis of NF1 bone diseases is largely unknown. There is no current treatment. By Nfl heterozygote （Nf1＋/-） mice and Nfl conditional knockout mice, we and other groups demonstrated abnormal osteoblast and osteoclast function due to dysregulation of Ras signaling. However, the specific downstream effector pathways linked to NF1 abnormal osteoblastogenesis and osteoclastogenesis have not been defined. In this study, we investigated the Ras downstream effector related with NF1 bone disease. Methods We used Nf1＋/＋ and Nf1＋/- mice as normal and NF1 models. Bone stromal cells extracted from Nf1＋/＋ and Nf1＋/- mice were induced osteoclasts. The osteoclast cell was stained by tartrate resistant acid phosphatase staining. The osteoclast cell number was counted and the surface area of osteoclast cells was calculated under the microscope. The mRNA of mammalian target of rapamycin （mTOR） was determined by quantitative reverse-transcription-polymerase chain reaction. The presence of ribosomal protein S6 kinase was determined by Western blotting. Results Compared with Nf1＋/＋ mice, Nf1＋/- mice had about 20% more of osteoclast cells. These osteoclast cells were larger in size with more nuclei. Hyperactive mTOR was detected in Nf1＋/- osteoclast cells. Inhibition of roTOR signaling by rapamycin in Nf1＋/- osteoclasts abrogated abnormalities in cellular size and number. Conclusion mTOR pathway inhibition may represent a viable therapy for NF1 bone diseases.展开更多
雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)作为PI3K/AKT/mTOR路径中主要的蛋白激酶,在胞内调节细胞生长、分化、凋亡以及肿瘤血管生成的信号传导中起重要作用。近年来人们发现mTOR及其相关激酶在神经内分泌肿瘤中表达升高,...雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)作为PI3K/AKT/mTOR路径中主要的蛋白激酶,在胞内调节细胞生长、分化、凋亡以及肿瘤血管生成的信号传导中起重要作用。近年来人们发现mTOR及其相关激酶在神经内分泌肿瘤中表达升高,于是特异性降低mTOR表达的药物成为继手术治疗肺类癌之外的又一选择。展开更多
文摘The mammalian target of rapamycin （mTOR） pathway plays an important role in neuronal growth, proliferation and differentiation. To better understand the role of mTOR pathway involved in the induction of spinal cord injury, rat models of spinal cord injury were established by modified Allen＇s stall method and interfered for 7 days by intraperitoneal administration of mTOR activator adenosine triphosphate and mTOR kinase inhibitor rapamycin. At 1-4 weeks after spinal cord injury induction, the Basso, Beattie and Bresnahan locomotor rating scale was used to evaluate rat locomotor function, and immunohistochemical staining and western blot analysis were used to detect the expression of nestin （neural stem cell marker）, neuronal nuclei （neuronal marker）, neuron specific enolase, neurofilament protein 200 （axonal marker）, glial fibrillary acidic protein （astrocyte marker）, Akt, mTOR and signal transduction and activator of transcription 3 （STAT3）. Results showed that adenosine triphosphate-mediated Akt/mTOR/STAT3 pathway increased endogenous neural stem cells, induced neurogenesis and axonal growth, inhibited excessive astrogliosis and improved the locomotor function of rats with spinal cord injury.
文摘慢性炎症是指刺激因素持续作用或其他原因导致的难以消退的炎症反应.它与许多重大疾病的发生、发展密切相关.近年来,慢性炎症在癌症发生发展中的关键作用得到普遍认可,其促癌作用的机制已成为当前生命科学研究热点之一.哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)是接受细胞内外各种信号、调节细胞生长与代谢的关键分子,多数肿瘤存在mTOR通路的过度激活.最近,我们与其他实验室的研究发现mTOR通路在"炎-癌"转变中起重要作用.本综述将对慢性炎症与癌症的关系、慢性炎症的促癌作用机制做一概括介绍,重点讨论mTOR信号通路介导慢性炎症促癌效应的作用、机制及未来研究方向,为慢性炎症恶性转化分子机制研究提供新的观点.
文摘Background： Triggering receptor expressed on myeloid cell- 1 （TREM- 1） may play a vital role in mammalian target ofrapamycin （mTOR） modulation ofCD8＋ T-cell differentiation through the transcription factors T-box expressed in T-cells and eomesodermin during the immune response to invasive pulmonary aspergillosis （IPA）. This study aimed to investigate whether the roTOR signaling pathway modulates the proliferation and differentiation of CD8＋ T-cells during the immune response to I PA and the role TREM-1 plays in this process. Methods： Cyclophosphamide （CTX） was injected intraperitoneally, and Asl？e;gillus.[mnigams spore suspension was inoculated intranasally to establish the immunosuppressed IPA mouse model. After inoculation, rapamycin （2 mg-kg ·d -1） or interleukin （IL）-12 （5 μg/kg every other day） was given for 7 days. The number of CD8＋ effector memory T-cells （Tern）, expression of interferon （IFN）-y, roTOR, and ribosomal protein $6 kinase （S6K）, and the levels of IL-6, IL- 10, galactomannan （GM）, and soluble TREM- 1 （sTREM-I） were measured. Results： Viable A. fumigatus was cultured from the lung tissue of the inoculated mice. Histological examination indicated greater inflammation, hemorrhage, and lung tissue injury in both IPA and CTX ＋ IPA mice groups. The expression of mTOR and S6K was significantly increased in the CTX ＋ IPA ＋ I L- 12 group compared with the control, I PA （P = 0.01 ; P - 0.001 ）, and CTX ＋ 1PA （P = 0.034; P = 0.032） groups, but significantly decreased in the CTX ＋ IPA ＋ RAPA group （P 〈 0.001 ）. Compared with the CTX ＋ IPA group, the proportion of Tern, expression of IFN-y, and the level ofsTREM-I were significantly higher after IL-12 treatment （P = 0.024, P = 0.032, and P = 0.017, respectively）, and the opposite results were observed when the roTOR pathway was blocked by rapamycin （P 〈 0.001）. Compared with the CTX ＋ I PA and CTX ＋ I PA ＋ RAPA groups, IL-12 treatment increased IL-6 and downregulated IL- 10 as well as G M, which strengthened the immune response to the IPA infection. Conclusions： mTOR modulates CD8＋ T-cell differentiation during the immune response to IPA. TREM-1 may play a vital role in signal transduction between mTOR and the downstream immune response.
文摘Background Neurofibromatosis type 1 （NF1） is the most common genetic syndrome predisposing patients to various tumors due to dysregulation of the Ras signaling pathway. Recent research has shown NF1 patients also suffer a spectrum of bone pathologies. The pathogenesis of NF1 bone diseases is largely unknown. There is no current treatment. By Nfl heterozygote （Nf1＋/-） mice and Nfl conditional knockout mice, we and other groups demonstrated abnormal osteoblast and osteoclast function due to dysregulation of Ras signaling. However, the specific downstream effector pathways linked to NF1 abnormal osteoblastogenesis and osteoclastogenesis have not been defined. In this study, we investigated the Ras downstream effector related with NF1 bone disease. Methods We used Nf1＋/＋ and Nf1＋/- mice as normal and NF1 models. Bone stromal cells extracted from Nf1＋/＋ and Nf1＋/- mice were induced osteoclasts. The osteoclast cell was stained by tartrate resistant acid phosphatase staining. The osteoclast cell number was counted and the surface area of osteoclast cells was calculated under the microscope. The mRNA of mammalian target of rapamycin （mTOR） was determined by quantitative reverse-transcription-polymerase chain reaction. The presence of ribosomal protein S6 kinase was determined by Western blotting. Results Compared with Nf1＋/＋ mice, Nf1＋/- mice had about 20% more of osteoclast cells. These osteoclast cells were larger in size with more nuclei. Hyperactive mTOR was detected in Nf1＋/- osteoclast cells. Inhibition of roTOR signaling by rapamycin in Nf1＋/- osteoclasts abrogated abnormalities in cellular size and number. Conclusion mTOR pathway inhibition may represent a viable therapy for NF1 bone diseases.
文摘雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)作为PI3K/AKT/mTOR路径中主要的蛋白激酶,在胞内调节细胞生长、分化、凋亡以及肿瘤血管生成的信号传导中起重要作用。近年来人们发现mTOR及其相关激酶在神经内分泌肿瘤中表达升高,于是特异性降低mTOR表达的药物成为继手术治疗肺类癌之外的又一选择。
